Low clinical penetrance of homozygosity for HFE C282Y: implications for genetic testing?

Suppr

超能文献

作者信息

Födinger M, Sunder-Plassmann G

出版信息

Eur J Clin Invest. 2003 Sep;33(9):737-9. doi: 10.1046/j.1365-2362.2003.01224.x.

DOI:10.1046/j.1365-2362.2003.01224.x

PMID:12925029

Abstract

摘要

相似文献

Low clinical penetrance of homozygosity for HFE C282Y: implications for genetic testing?

Eur J Clin Invest. 2003 Sep;33(9):737-9. doi: 10.1046/j.1365-2362.2003.01224.x.

[Molecular genetic diagnostics and screening of hereditary hemochromatosis].

Vnitr Lek. 2006 Jun;52(6):602-8.

What is HFE haemochromatosis?

Br J Hosp Med (Lond). 2016 Jun;77(6):C91-5. doi: 10.12968/hmed.2016.77.6.C91.

Clinical penetrance of C282Y homozygous HFE hemochromatosis in a western Romanian population.

J Gastrointestin Liver Dis. 2011 Mar;20(1):100-1.

Clinical penetrance of C282Y homozygous HFE hemochromatosis.

Expert Rev Hematol. 2008 Dec;1(2):205-16. doi: 10.1586/17474086.1.2.205.

[Hemochromatosis, a public health problem].

Soins. 2007 Jun(716):34-5.

Screening for C282Y homozygosity in a Norwegian population (HUNT2): The sensitivity and specificity of transferrin saturation.

Scand J Clin Lab Invest. 2010 Apr;70(2):92-7. doi: 10.3109/00365510903527838.

Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?

J Med Genet. 2005 May;42(5):390-5. doi: 10.1136/jmg.2004.027284.

Expression of the HFE hemochromatosis gene in a community-based population of elderly women.

J Gastroenterol Hepatol. 2004 Oct;19(10):1150-4. doi: 10.1111/j.1440-1746.2004.03436.x.

Prevalence of the C282Y mutation in Brittany: penetrance of genetic hemochromatosis?

Ann Genet. 1998;41(4):195-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Low clinical penetrance of homozygosity for HFE C282Y: implications for genetic testing?

Eur J Clin Invest. 2003 Sep;33(9):737-9. doi: 10.1046/j.1365-2362.2003.01224.x.

[Molecular genetic diagnostics and screening of hereditary hemochromatosis].

Vnitr Lek. 2006 Jun;52(6):602-8.

What is HFE haemochromatosis?

Br J Hosp Med (Lond). 2016 Jun;77(6):C91-5. doi: 10.12968/hmed.2016.77.6.C91.

Clinical penetrance of C282Y homozygous HFE hemochromatosis in a western Romanian population.

J Gastrointestin Liver Dis. 2011 Mar;20(1):100-1.

Clinical penetrance of C282Y homozygous HFE hemochromatosis.

Expert Rev Hematol. 2008 Dec;1(2):205-16. doi: 10.1586/17474086.1.2.205.

[Hemochromatosis, a public health problem].

Soins. 2007 Jun(716):34-5.

Screening for C282Y homozygosity in a Norwegian population (HUNT2): The sensitivity and specificity of transferrin saturation.

Scand J Clin Lab Invest. 2010 Apr;70(2):92-7. doi: 10.3109/00365510903527838.

Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?

J Med Genet. 2005 May;42(5):390-5. doi: 10.1136/jmg.2004.027284.

Expression of the HFE hemochromatosis gene in a community-based population of elderly women.

J Gastroenterol Hepatol. 2004 Oct;19(10):1150-4. doi: 10.1111/j.1440-1746.2004.03436.x.

Prevalence of the C282Y mutation in Brittany: penetrance of genetic hemochromatosis?

Ann Genet. 1998;41(4):195-8.